Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including additional amendments thereto) with respect to the Common Stock, par value $0.0001 per share, of Ocuphire Pharma, Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: May 16, 2022
| Richmond Brothers, Inc. | |||
| By: | /s/ David S. Richmond | ||
| Name: | David S. Richmond | ||
| Title: | Chairman | ||
| The RBI Opportunities Fund, LLC | |||
| By: | RBI PI Manager, LLC | ||
| Manager | |||
| By: | /s/ David S. Richmond | ||
| Name: | David S. Richmond | ||
| Title | Manager | ||
| The RBI Opportunities Fund II, LLC | |||
| By: |
RBI PI Manager, LLC Manager | ||
| By: | /s/ David S. Richmond | ||
| Name: | David S. Richmond | ||
| Title: | Manager | ||
| RBI Private Investment III, LLC | |||
| By: |
RBI PI Manager, LLC Manager | ||
| By: | /s/ David S. Richmond | ||
| Name: | David S. Richmond | ||
| Title | Manager | ||
| Richmond Brothers 401(k) Profit Sharing Plan | |||
| By: | /s/ David S. Richmond | ||
| Name: | David S. Richmond | ||
| Title | Trustee | ||
| /s/ David S. Richmond | |||
| Name: | David S. Richmond | ||
| /s/ Matthew J. Curfman | |||
| Name: | Matthew J. Curfman | ||